SCHEMBL6065740

SCHEMBL6065740

Cc1n[nH]c(NC(c2ccccc2)(c2ccccc2)c2ccccc2)c1NC(=O)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.41
F12 P00748 1/20 0.41
ALDH1A1 P00352 12/20 0.40
MAPT P10636 7/20 0.40
KDM4E B2RXH2 5/20 0.40
NPSR1 Q6W5P4 3/20 0.40
RAB9A P51151 2/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 3/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
THRB P10828 1/20 0.38
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
GAA P10253 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 2/20 0.37
HPGD P15428 2/20 0.37
IDO1 P14902 1/20 0.37
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6066190 0.83 SMN1; SMN2 (0.35) MAPTKDM4ERAB9AKMT2ASMN1; SMN2
SCHEMBL6065131 0.81 LMNA (0.40) ALDH1A1KDM4ERAB9AGAASMN1; SMN2
SCHEMBL6065097 0.79 PKM (0.45) F2ALDH1A1MAPTKDM4ECYP1A2
SCHEMBL6065953 0.77 F2 (0.46) F2F12ALDH1A1MAPTKDM4E
SCHEMBL6065771 0.75 LMNA (0.35) ALDH1A1GAASMN1; SMN2HTTLMNA
SCHEMBL6065016 0.74 KMT2A (0.33) MAPTRAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL20064247 0.72 ALDH1A1 (0.43) F2F12ALDH1A1MAPTKDM4E
SCHEMBL6557414 0.70 MTNR1A (0.40) ALDH1A1MAPTRAB9AHSD17B10CYP1A2
SCHEMBL6558343 0.69 NPC1 (0.41) ALDH1A1MAPTKDM4ERAB9AHSD17B10
SCHEMBL6557067 0.69 P2RX3 (0.35) ALDH1A1MAPTKDM4ERAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663245-A1 CEPHEM COMPOUNDS Astellas Pharma Inc. (JP) 2006-06-07 EP disclosed
EP-1556389-A1 CEPHEM COMPOUNDS Astellas Pharma Inc. (JP) 2005-07-27 EP disclosed
WO-2005027909-A1 CEPHEM COMPOUNDS ASTELLAS PHARMA INC. (JP) 2005-03-31 WO disclosed
WO-2004039814-A1 CEPHEM COMPOUNDS ASTELLAS PHARMA INC. (JP) 2004-05-13 WO disclosed